FDA Adverse Event Malfunction Summary report: N

ENDOTAK RELIANCE

MDR report key: 3213031 · Received July 9, 2013

Report

Report Number
2124215-2013-10147
Event Type
Malfunction
Date Received
July 9, 2013
Date of Event
November 1, 2012
Report Date
June 19, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THE LEAD WILL BE REPLACED IN THE NEAR FUTURE. NO OTHER ADVERSE EVENTS HAVE BEEN REPORTED. THIS PRODUCT ISSUE WILL BE UPDATED IF ADDITIONAL INFORMATION IS RECEIVED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR (RV) LEAD HAD BEEN EXHIBITING INCREASED PACING IMPEDANCE MEASUREMENTS WHICH WERE REPORTED TO BE GREATER THAN 2000 OHMS. THRESHOLD AND SENSING MEASUREMENTS REMAINED UNCHANGED. A LEAD REVISION IS BEING PERFORMED IN THE NEAR FUTURE TO REPLACE THIS LEAD. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
313496 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0148

Patients

Seq Age Sex Outcome Treatment
1 48 YR E102| 0148